** Shares of Kaiser Permanente-backed healthcare startup CAMP4 Therapeutics rise 1.45% above their initial public offering price in co's market debut
** CAMP last up ~1% at $11.11; stock opened trading at $11.16 vs IPO price of $11
** With the rise in shares, CAMP is now valued a $197.37 mln
** Co raised $75 mln by selling 6.82 mln shares priced at $11 apiece, lower than its marketed range of $14 to $16
** J.P. Morgan, Leerink Partners, Piper Sandler and William Blair were the underwriters for the IPO
(Reporting by Prakhar Srivastava in Bengaluru)
((Prakhar.srivastava2@thomsonreuters.com))